Queen Mary University London
About
Throughout our history, we’ve fostered social justice and improved lives through academic excellence. And we continue to live and breathe this spirit today, not because it’s simply ‘the right thing to do’ but for what it helps us achieve and the intellectual brilliance it delivers.
Our reformer heritage informs our conviction that great ideas can and should come from anywhere. It’s an approach that has brought results across the globe, from the communities of east London to the favelas of Rio de Janeiro.
We continue to embrace diversity of thought and opinion in everything we do, in the belief that when views collide, disciplines interact, and perspectives intersect, truly original thought takes form.
Cluster 1: Health
HORIZON-HLTH-2027-01-STAYHLTH-01: Addressing disabilities through the life course to support independent living and inclusion HOHORIZON-HLTH-2027-01-ENVHLTH-02: Integrating climate-related exposures into the human exposome and characterising its changes in response to climate changeHORIZON-HLTH-2027-01-ENVHLTH-MISSCLIMA-03: Tools and technologies to support health adaptation to climate changeHORIZON-HLTH-2027-01-DISEASE-05: Development of novel small molecule antiviral therapeutics for pathogens with epidemic potentialHORIZON-HLTH-2027-01-DISEASE-06: Development of monoclonal antibodies to prevent and treat infections from FlavivirusesHORIZON-HLTH-2027-01-DISEASE-07: Development of monoclonal antibodies to prevent and treat infections from Filo-, Nairo-, Phenui-, Picorna- and Toga virusesHORIZON-HLTH-2027-01-DISEASE-08: Development of innovative antimicrobials against pathogens resistant to antimicrobialsHORIZON-HLTH-2027-01-DISEASE-10: Prevention and management of chronic non-communicable diseases in children and young people (GACD)HORIZON-HLTH-2027-02-DISEASE-01-two-stage: Innovative healthcare interventions for non-communicable diseasesHORIZON-HLTH-2027-02-DISEASE-14-two-stage: Clinical trials for advancing innovative interventions for neurodegenerative diseasesHORIZON-HLTH-2027-01-CARE-02: Personalised approaches to reduce risks from Adverse Drug Reactions due to administration of multiple medicationsHORIZON-HLTH-2027-02-TOOL-01-two-stage: Development of predictive biomarkers of disease progression and treatment response by using AI methodologies for chronic non-communicable diseasesHORIZON-HLTH-2027-03-TOOL-02: Advancing bio-printing of living cells for regenerative medicineHORIZON-HLTH-2027-03-TOOL-04: Virtual Human Twins (VHTs) for integrated clinical decision support in prevention and diagnosisHORIZON-HLTH-2027-03-TOOL-08: Towards Artificial General Intelligence (AGI) for healthcareHORIZON-HLTH-2027-01-IND-01: Development of cell-free protein synthesis platforms for discovery and/or production of biologicalsHORIZON-HLTH-2027-02-IND-02-two-stage: Portable and versatile Point-of-care diagnostics
Cluster 4: Digital & Industry
HORIZON-CL4-2027-04-DATA-09: Energy efficiency and sustainability of AI data processing in Data CentresHORIZON-CL4-2027-04-DIGITAL-EMERGING-06: International cooperation in AIHORIZON-CL4-2027-05-DIGITAL-EMERGING-03: Advanced integrated photonic devices for extended features and ultra-low power consumptionHORIZON-CL4-2027-04-DIGITAL-EMERGING-10: Horizon scanning and foresight in future enabling digital technologiesHORIZON-CL4-2027-04-HUMAN-01: Advanced and Innovative hardware components for Virtual Worlds (Virtual Worlds Partnership)HORIZON-CL4-2027-04-HUMAN-02: Create A thriving and competitive Virtual Worlds and Web4.0 ecosystem (Virtual Worlds Partnership)HORIZON-CL4-2027-04-HUMAN-07: Facilitate the engagement of European stakeholders in international digital standardisationHORIZON-CL4-2027-02-DIGITAL-EMERGING-52-two-stage: New approaches for Human/AI collaboration for the workforce of the future (Made in Europe and AI, Data and Robotics partnerships)HORIZON-CL4-2027-01-MATERIALS-PRODUCTION-02: Advanced manufacturing for key products (Made in Europe partnership)HORIZON-CL4-2027-01-MATERIALS-PRODUCTION-03: Factory processes and automation for de- and re-manufacturing (Made in Europe partnership)HORIZON-CL4-2027-01-MATERIALS-PRODUCTION-06: Circular innovative advanced materials: facilitating the transition from design to markets (Innovative Advanced Materials for the EU and Made in Europe partnerships)HORIZON-CL4-2027-01-MATERIALS-PRODUCTION-08: Textile circularity through advanced processing and manufacturing technologies and system approaches (Textiles for the Future partnership)HORIZON-CL4-2027-01-MATERIALS-PRODUCTION-22: Innovative advanced materials and new production processes – reducing dependencies on Critical and Strategic Raw Materials (Innovative Advanced Materials for the EU and Processes4Planet partnerships)HORIZON-CL4-2027-02-MATERIALS-PRODUCTION-32-two-stage: Efficient energy input from renewable sources and energy management in the process industriesHORIZON-CL4-2027-01-MATERIALS-PRODUCTION-42: Unlocking the potential of academic intellectual assets for industry, SMEs and startupsHORIZON-CL4-2027-01-MATERIALS-PRODUCTION-47: Pilot access schemes to Technology Infrastructures for European startups, scaleups and innovative SMEs
Representatives
Professor of Computational Biology, AI & Emerging Tech
Queen Mary University London